Related Experiment Videos
Compliance. What's around the corner?
1Orlando Regional Healthcare System, College of Health and Public Affairs, University of Central Florida, Orlando, USA. sshowal@orhs.org
Summary
Compliance and finance leaders must collaborate to uphold organizational ethics. Addressing clinical research billing, especially Medicare payments for experimental devices, is crucial for financial integrity and revenue optimization.
Area of Science:
- Healthcare Compliance
- Financial Management in Clinical Research
- Medical Billing Regulations
Background:
- Financial and compliance challenges frequently originate within clinical research operations.
- Adherence to specific billing regulations is essential for experimental devices, particularly when funded by Medicare.
- Protected health information breaches carry significant financial repercussions.
Purpose of the Study:
- To emphasize the critical need for collaboration between compliance officers and financial managers.
- To highlight key areas of financial and compliance risk in healthcare organizations.
- To underscore the importance of accurate billing practices and data protection.
Main Methods:
- Analysis of common financial and compliance issues in clinical research.
- Review of Medicare billing guidelines for experimental devices.
- Examination of the impact of protected health information violations.
Main Results:
- A strong alliance between compliance and finance is vital for organizational ethics and integrity.
- Clinical research presents numerous financial and compliance risks that require careful management.
- Detailed attention to the charge description master can enhance efficiency and net revenue.
- Violations concerning protected health information can lead to substantial financial penalties.
Conclusions:
- Proactive collaboration between compliance and finance departments is essential for mitigating risks.
- Accurate and compliant billing, particularly for experimental medical devices, is critical for financial health.
- Robust protection of patient health information is paramount to avoid severe financial and reputational damage.